Cathepsin K inhibitors for osteoporosis and potential off-target effects

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.18, Iss.5, 2009-05, pp. : 585-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cathepsin K Inhibitors: A Novel Target but Promising Approach in the Treatment of Osteoporosis

Current Drug Targets, Vol. 14, Iss. 13, 2013-12 ,pp. : 1591-1600

Bentham Science Publishers

Access to resources Recommend Favorite

Cathepsin K as a target for the treatment of osteoporosis

By Smith W.W. Abdel-Meguid S.S.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 683-694

Informa Healthcare

Access to resources Recommend Favorite

Design of Cathepsin K Inhibitors for Osteoporosis

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 16, 2005-12 ,pp. : 1639-1675

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Covalent Cathepsin K Inhibitors for the Treatment of Osteoporosis

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 355-360

Bentham Science Publishers

Access to resources Recommend Favorite

Peptidomimetic Inhibitors of Cathepsin K

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 7, 2010-05 ,pp. : 745-751

Bentham Science Publishers

Access to resources Recommend Favorite